Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles 
Bill Ackman Eyes New Fund to Bet Against Market Complacency 
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb 
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes 
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect 
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts 
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis 
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase 
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts 
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict 
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push 
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58% 
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute 
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk 
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements 
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 
 Shares Announced by Shareholders Foundation - EconoTimes)
SAN DIEGO, Jan. 27, 2016 -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in New York on behalf of certain investors who purchased of shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) over alleged Securities Laws Violations by Anavex Life Sciences.
Investors who purchased shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) have certain options and for certain investors are short and strict deadlines running. Deadline: February 29, 2016. (NASDAQ:AVXL) investors should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
The plaintiff claims that the defendants made certain allegedly false and/or misleading statements and/or allegedly failed to disclose that Anavex had used a paid stock promoter to artificially inflate the Company’s share price and that as a result of the foregoing, Anavex’s public statements were materially false and misleading at all relevant times.
On December 29, 2015, Anavex Life Sciences Corp. disclosed that it had received a subpoena from the U.S. Securities and Exchange Commission (“SEC”) on December 22, 2015. Anavex Life Sciences Corp. stated, in part, that "[t]he Company believes the subpoena and investigation relate to the recent unusual activity in the market for the Company's shares."
On December 30, 2015, a report was published entitled “Anavex: A Regulatory Target Damaged By Incriminating Evidence.”
Those who purchased (NASDAQ:AVXL) shares have certain options and should contact the Shareholders Foundation, Inc. by e-mail at [email protected] or call +1 (858) 779-1554.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT: Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
[email protected]
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
